173 related articles for article (PubMed ID: 16053123)
1. The use of probiotics in the treatment of irritable bowel syndrome: two case reports.
Faber S; Rigden S; Lukaczer D
Altern Ther Health Med; 2005; 11(4):60-2. PubMed ID: 16053123
[No Abstract] [Full Text] [Related]
2. The use of probiotics in the treatment of irritable bowel syndrome.
Gaby AR
Altern Ther Health Med; 2006; 12(1):17; author reply 17. PubMed ID: 16454141
[No Abstract] [Full Text] [Related]
3. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
4. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
5. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome: the possible benefits of probiotics.
Isselbacher KJ
Postgrad Med; 2005 May; 117(5):7. PubMed ID: 15948360
[No Abstract] [Full Text] [Related]
7. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
8. Probiotics in irritable bowel syndrome: underachievers or underpowered?
Ford AC
Aliment Pharmacol Ther; 2010 Apr; 31(8):922-3; author reply 923-4. PubMed ID: 20415830
[No Abstract] [Full Text] [Related]
9. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
[TBL] [Abstract][Full Text] [Related]
10. Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome.
van Zanten SV
Gastroenterology; 2005 Aug; 129(2):772; author 772-3. PubMed ID: 16083745
[No Abstract] [Full Text] [Related]
11. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
12. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
Dughera L; Elia C; Navino M; Cisarò F;
Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
[TBL] [Abstract][Full Text] [Related]
13. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-physiological rationale for the use of the mesodiencephalic modulation in combination with synobiotics in the irritable bowel syndrome].
Efendieva MT; Gusakova EV
Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (2):25-8. PubMed ID: 18507185
[No Abstract] [Full Text] [Related]
15. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.
Agrawal A; Houghton LA; Morris J; Reilly B; Guyonnet D; Goupil Feuillerat N; Schlumberger A; Jakob S; Whorwell PJ
Aliment Pharmacol Ther; 2009 Jan; 29(1):104-14. PubMed ID: 18801055
[TBL] [Abstract][Full Text] [Related]
16. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
[TBL] [Abstract][Full Text] [Related]
17.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
18. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
19. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
20. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
Diaz Ferrer J; Parra V; Bendaño T; Montes P; Solorzano P
Rev Gastroenterol Peru; 2012; 32(4):387-93. PubMed ID: 23307089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
